Macrolide Resistance and <i>In Vitro</i> Potentiation by Peptidomimetics in Porcine Clinical Escherichia coli-Reference-Cited by-同舟云学术

Macrolide Resistance and In Vitro Potentiation by Peptidomimetics in Porcine Clinical Escherichia coli

Published:2022-10-26 Issue:5 Volume:7 Page:
ISSN:2379-5042
Container-title:mSphere
language:en
Short-container-title:mSphere

Author:

Ma Yibing¹,Pirolo Mattia¹^ORCID,Subramani Prabha¹,Gehring Ronette²,Damborg Peter¹^ORCID,Franzyk Henrik³^ORCID,Guardabassi Luca¹^ORCID

Affiliation:

1. Department of Veterinary and Animal Sciences, University of Copenhagen, Copenhagen, Denmark

2. Institute of Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands

3. Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark

Abstract

Acquired macrolide resistance is poorly studied in Escherichia coli because of intrinsic resistance and limited antimicrobial activity in Gram-negative bacteria. This study reveals new information on the prevalence and distribution of macrolide resistance determinants in a comprehensive collection of porcine clinical E. coli from Denmark.

Funder

EC | Horizon Europe | Excellent Science | HORIZON EUROPE Marie Sklodowska-Curie Actions

Publisher

American Society for Microbiology

Subject

Molecular Biology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/msphere.00402-22

Reference38 articles.

1. Optimization of Antimicrobial Treatment to Minimize Resistance Selection

2. Antibiotic resistance in porcine pathogenic bacteria and relation to antibiotic usage

3. Indications for the use of highest priority critically important antimicrobials in the veterinary sector